Henry Schein | HSIC - Cost Of Sales

Stock Price
72.12
Daily Change
-0.59 -0.81%
Monthly
-8.88%
Yearly
0.39%
Q2 Forecast
71.26

Henry Schein reported $2.3B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Align Technology USD 303.5M 60.47M Mar/2026
Bruker USD 443.6M 84.4M Mar/2026
Cardinal Health USD 58.54B 4.82B Mar/2026
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Cigna USD 62.41B 4.1B Mar/2026
Concord Medical Services Hldg CNY 204.9M 117.04M Jun/2025
Cooper Companies USD 376.8M 87.4M Dec/2025
CVS Health USD 84.8B 7.32B Mar/2026
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 453M 65M Mar/2026
Encompass Health USD 151.6M 700K Mar/2026
Henry Schein USD 2.3B 145M Mar/2026
Idexx Laboratories USD 418.08M 14.38M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Laboratory Of America USD 2.6B 4.2M Mar/2026
McKesson USD 92.25B 10.22B Mar/2026
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Owens Minor USD 436.92M 32.62M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Tenet Healthcare USD 1.19B 51M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Universal Health Services USD 422.76M 2.06B Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Waters USD 725M 350.06M Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026
Zoetis USD 672M 71M Mar/2026